American Gene Technologies to Present at The Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference

Rockville, Maryland–(Newsfile Corp. – August 25, 2026) – American Gene Technologies, is a clinical-stage biotechnology company developing AGT103-T, a one-time gene-modified T-cell therapy that is the only program to demonstrate elimination of the HIV viral reservoir in humans., is pleased to announce its participation at the upcoming Moody Capital Solutions 2026 Disruptive Growth & Life […]